ReP USP - Resultado da busca

Artigo de periodico
P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV (2023)
Moreira, Fernanda de Lima; Melli, Patrícia Pereira dos Santos; Marques, Maria Paula ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Duarte, Geraldo; Lanchote, Vera Lucia
Fonte: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, INFECÇÕES POR HIV, INTERAÇÃO DE MEDICAMENTOS, GRAVIDEZ, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV. The Journal of Clinical Pharmacology, v. 63, n. 2, p. 219-227, 2023Tradução . . Disponível em: https://doi.org/10.1002/jcph.2152. Acesso em: 31 out. 2024.
APA
Moreira, F. de L., Melli, P. P. dos S., Marques, M. P., Rocha, A., Nardotto, G. H. B., Duarte, G., & Lanchote, V. L. (2023). P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV. The Journal of Clinical Pharmacology, 63( 2), 219-227. doi:10.1002/jcph.2152
NLM
Moreira F de L, Melli PP dos S, Marques MP, Rocha A, Nardotto GHB, Duarte G, Lanchote VL. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 2): 219-227.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/jcph.2152
Vancouver
Moreira F de L, Melli PP dos S, Marques MP, Rocha A, Nardotto GHB, Duarte G, Lanchote VL. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 2): 219-227.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/jcph.2152
Artigo de periodico
10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study (2022)
Cuoghi, Isabela Campeti; Soares, Mariana Furlani da Silva; Santos, Gustavo Motta Cabello dos; Reis, Francisco José Candido dos ; Poli Netto, Omero Benedicto ; Andrade, Jurandyr Moreira de ; Bosquesi, Priscila Longhin; Orlandini, Leonardo Fleury ; Tiezzi, Daniel Guimarães
Fonte: Journal of Global Health. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, DIAGNÓSTICO POR IMAGEM, ESTUDOS TRANSVERSAIS, DIAGNÓSTICO PRECOCE, MAMOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUOGHI, Isabela Campeti et al. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study. Journal of Global Health, v. 12, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.7189/jogh.12.04061. Acesso em: 31 out. 2024.
APA
Cuoghi, I. C., Soares, M. F. da S., Santos, G. M. C. dos, Reis, F. J. C. dos, Poli Netto, O. B., Andrade, J. M. de, et al. (2022). 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study. Journal of Global Health, 12, 1-9. doi:10.7189/jogh.12.04061
NLM
Cuoghi IC, Soares MF da S, Santos GMC dos, Reis FJC dos, Poli Netto OB, Andrade JM de, Bosquesi PL, Orlandini LF, Tiezzi DG. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study [Internet]. Journal of Global Health. 2022 ; 12 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.7189/jogh.12.04061
Vancouver
Cuoghi IC, Soares MF da S, Santos GMC dos, Reis FJC dos, Poli Netto OB, Andrade JM de, Bosquesi PL, Orlandini LF, Tiezzi DG. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study [Internet]. Journal of Global Health. 2022 ; 12 1-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.7189/jogh.12.04061
Artigo de periodico
Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings (2022)
Moterani Junior, Nino Jose Wilson; Moterani, Vinicius César; Moterani, Laura Bresciani Bento Gonçalves; Pimentel, Franklin Fernandes; Reis, Francisco José Cândido dos
Fonte: Revista Associação Médica Brasileira. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, DIAGNÓSTICO PRECOCE, COVID-19, MAMOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTERANI JUNIOR, Nino Jose Wilson et al. Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings. Revista Associação Médica Brasileira, v. 68, n. 6, p. 842-846, 2022Tradução . . Disponível em: https://doi.org/10.1590/1806-9282.20220182. Acesso em: 31 out. 2024.
APA
Moterani Junior, N. J. W., Moterani, V. C., Moterani, L. B. B. G., Pimentel, F. F., & Reis, F. J. C. dos. (2022). Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings. Revista Associação Médica Brasileira, 68( 6), 842-846. doi:10.1590/1806-9282.20220182
NLM
Moterani Junior NJW, Moterani VC, Moterani LBBG, Pimentel FF, Reis FJC dos. Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings [Internet]. Revista Associação Médica Brasileira. 2022 ; 68( 6): 842-846.[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1806-9282.20220182
Vancouver
Moterani Junior NJW, Moterani VC, Moterani LBBG, Pimentel FF, Reis FJC dos. Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings [Internet]. Revista Associação Médica Brasileira. 2022 ; 68( 6): 842-846.[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1806-9282.20220182
Artigo de periodico
A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples (2022)
Dantas, Felipe Torres; Silva, Pedro Henrique Felix ; Carrara, Helio Humberto Angotti ; Reis, Francisco José Candido dos ; Taba Júnior, Mário ; Souza, Sérgio Luis Scombatti de ; Palioto, Daniela Bazan
Fonte: Anticancer Research. Unidades: FMRP, FORP
Assuntos: BIOMARCADORES, BIÓPSIA COM AGULHA DE GRANDE CALIBRE, NEOPLASIAS MAMÁRIAS, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTAS, Felipe Torres et al. A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples. Anticancer Research, v. 42, n. 3, p. 1327-1332, 2022Tradução . . Disponível em: https://doi.org/10.21873/anticanres.15600. Acesso em: 31 out. 2024.
APA
Dantas, F. T., Silva, P. H. F., Carrara, H. H. A., Reis, F. J. C. dos, Taba Júnior, M., Souza, S. L. S. de, & Palioto, D. B. (2022). A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples. Anticancer Research, 42( 3), 1327-1332. doi:10.21873/anticanres.15600
NLM
Dantas FT, Silva PHF, Carrara HHA, Reis FJC dos, Taba Júnior M, Souza SLS de, Palioto DB. A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples [Internet]. Anticancer Research. 2022 ; 42( 3): 1327-1332.[citado 2024 out. 31 ] Available from: https://doi.org/10.21873/anticanres.15600
Vancouver
Dantas FT, Silva PHF, Carrara HHA, Reis FJC dos, Taba Júnior M, Souza SLS de, Palioto DB. A new method for obtaining tumor interstitial fluid applied to cytokine analysis of breast carcinoma samples [Internet]. Anticancer Research. 2022 ; 42( 3): 1327-1332.[citado 2024 out. 31 ] Available from: https://doi.org/10.21873/anticanres.15600
Artigo de periodico
Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil (2022)
Magario, Marcos Benini; Santos, Raquel Rocha dos ; Teixeira, Lorena Alves ; Tiezzi, Daniel Guimarães ; Pimentel, Franklin Fernandes ; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, PROGNÓSTICO, SOBREVIDA, VALIDAÇÃO DE MODELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAGARIO, Marcos Benini et al. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil. Brazilian Journal of Medical and Biological Research, v. 55, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2022e12109. Acesso em: 31 out. 2024.
APA
Magario, M. B., Santos, R. R. dos, Teixeira, L. A., Tiezzi, D. G., Pimentel, F. F., Carrara, H. H. A., et al. (2022). Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil. Brazilian Journal of Medical and Biological Research, 55, 1-8. doi:10.1590/1414-431X2022e12109
NLM
Magario MB, Santos RR dos, Teixeira LA, Tiezzi DG, Pimentel FF, Carrara HHA, Andrade JM de, Reis FJC dos. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1414-431X2022e12109
Vancouver
Magario MB, Santos RR dos, Teixeira LA, Tiezzi DG, Pimentel FF, Carrara HHA, Andrade JM de, Reis FJC dos. Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-8.[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1414-431X2022e12109
Artigo de periodico
Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil (2021)
Orlandini, Leonardo Fleury ; Antonio, Maria Vitoria do Nascimento; Espreafico Junior, Claiver Renato; Bosquesi, Priscila Longhin; Poli Netto, Omero Benedicto; Andrade, Jurandyr Moreira de ; Reis, Francisco José Cândido dos; Tiezzi, Daniel Guimarães
Fonte: JCO Global Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, ANÁLISE DE DADOS, EPIDEMIOLOGIA, ESTUDOS RETROSPECTIVOS, MEIA IDADE, INCIDÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil. JCO Global Oncology, v. 7, p. 81-88, 2021Tradução . . Disponível em: https://doi.org/10.1200/GO.20.00440. Acesso em: 31 out. 2024.
APA
Orlandini, L. F., Antonio, M. V. do N., Espreafico Junior, C. R., Bosquesi, P. L., Poli Netto, O. B., Andrade, J. M. de, et al. (2021). Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil. JCO Global Oncology, 7, 81-88. doi:10.1200/GO.20.00440
NLM
Orlandini LF, Antonio MV do N, Espreafico Junior CR, Bosquesi PL, Poli Netto OB, Andrade JM de, Reis FJC dos, Tiezzi DG. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil [Internet]. JCO Global Oncology. 2021 ; 7 81-88.[citado 2024 out. 31 ] Available from: https://doi.org/10.1200/GO.20.00440
Vancouver
Orlandini LF, Antonio MV do N, Espreafico Junior CR, Bosquesi PL, Poli Netto OB, Andrade JM de, Reis FJC dos, Tiezzi DG. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil [Internet]. JCO Global Oncology. 2021 ; 7 81-88.[citado 2024 out. 31 ] Available from: https://doi.org/10.1200/GO.20.00440
Artigo de periodico
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers (2021)
Mattos-Arruda, Leticia De; Cortes, Javier; Blanco-Heredia, Juan; Tiezzi, Daniel Guimarães ; Villacampa, Guillermo; Gonçalves-Ribeiro, Samuel; Paré, Laia; Souza, Carla Anjos; Ortega, Vanesa; Sammut, Stephen-John
Fonte: NPJ Breast Cancer. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA, TERAPIA BIOLÓGICA, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTOS-ARRUDA, Leticia De et al. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. NPJ Breast Cancer, v. 7, n. 73, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41523-021-00282-0. Acesso em: 31 out. 2024.
APA
Mattos-Arruda, L. D., Cortes, J., Blanco-Heredia, J., Tiezzi, D. G., Villacampa, G., Gonçalves-Ribeiro, S., et al. (2021). The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. NPJ Breast Cancer, 7( 73), 1-10. doi:10.1038/s41523-021-00282-0
NLM
Mattos-Arruda LD, Cortes J, Blanco-Heredia J, Tiezzi DG, Villacampa G, Gonçalves-Ribeiro S, Paré L, Souza CA, Ortega V, Sammut S-J. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers [Internet]. NPJ Breast Cancer. 2021 ; 7( 73): 1-10.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41523-021-00282-0
Vancouver
Mattos-Arruda LD, Cortes J, Blanco-Heredia J, Tiezzi DG, Villacampa G, Gonçalves-Ribeiro S, Paré L, Souza CA, Ortega V, Sammut S-J. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers [Internet]. NPJ Breast Cancer. 2021 ; 7( 73): 1-10.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41523-021-00282-0
Trabalho de evento-resumo periodico
Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system (2021)
Pimentel, Franklin Fernandes; Buzatto, Isabela Panzeri Carlotti; Rodrigues, Tamara Cristina Gomes Ferraz; Borba, Jéssica Maria Camargo; Peruchi, Karoline P. I.; Andrade, Jurandyr Moreira de ; Tiezzi, Daniel Guimarães
Fonte: Cancer Research. Nome do evento: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, NEOPLASIAS MAMÁRIAS, MENOPAUSA, SISTEMA ÚNICO DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27. Acesso em: 31 out. 2024. , 2021
APA
Pimentel, F. F., Buzatto, I. P. C., Rodrigues, T. C. G. F., Borba, J. M. C., Peruchi, K. P. I., Andrade, J. M. de, & Tiezzi, D. G. (2021). Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS9-27
NLM
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 out. 31 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Vancouver
Pimentel FF, Buzatto IPC, Rodrigues TCGF, Borba JMC, Peruchi KPI, Andrade JM de, Tiezzi DG. Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 out. 31 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS9-27
Artigo de periodico
Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: asystematic review of clinical trials (2021)
Pilger, Taynara Louisi; Francisco, Daniely Franco ; Reis, Francisco José Cândido dos
Fonte: European Journal of Surgical Oncology. Unidade: FMRP
Assuntos: BIÓPSIA, LINFONODOS, NEOPLASIAS MAMÁRIAS, DISSECÇÃO, COMPLICAÇÕES INTRAOPERATÓRIAS, MEMBROS SUPERIORES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PILGER, Taynara Louisi e FRANCISCO, Daniely Franco e REIS, Francisco José Cândido dos. Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: asystematic review of clinical trials. European Journal of Surgical Oncology, v. 47, n. 7, p. 1497-1506, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejso.2021.01.024. Acesso em: 31 out. 2024.
APA
Pilger, T. L., Francisco, D. F., & Reis, F. J. C. dos. (2021). Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: asystematic review of clinical trials. European Journal of Surgical Oncology, 47( 7), 1497-1506. doi:10.1016/j.ejso.2021.01.024
NLM
Pilger TL, Francisco DF, Reis FJC dos. Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: asystematic review of clinical trials [Internet]. European Journal of Surgical Oncology. 2021 ; 47( 7): 1497-1506.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejso.2021.01.024
Vancouver
Pilger TL, Francisco DF, Reis FJC dos. Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: asystematic review of clinical trials [Internet]. European Journal of Surgical Oncology. 2021 ; 47( 7): 1497-1506.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.ejso.2021.01.024
Artigo de periodico
Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients (2021)
Orlandini, Leonardo Fleury ; Pimentel, F. F.; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos; Mattos-Arruda, L. de; Tiezzi, Daniel Guimarães
Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, OBESIDADE, PROGNÓSTICO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, v. 54, n. 10, 2021Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2021e11409. Acesso em: 31 out. 2024.
APA
Orlandini, L. F., Pimentel, F. F., Andrade, J. M. de, Reis, F. J. C. dos, Mattos-Arruda, L. de, & Tiezzi, D. G. (2021). Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, 54( 10). doi:10.1590/1414-431X2021e11409
NLM
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Vancouver
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2024 out. 31 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Artigo de periodico
Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients (2021)
Buzatto, Isabela Panzeri Carlotti ; Reis, Francisco José Candido dos ; Andrade, Jurandyr Moreira de ; Rodrigues, Tamara Cristina Gomes Ferraz; Borba, Jéssica Maria Camargo; Netto, Amanda Homse; Polydoro, Marina Sconzo; Tiezzi, Daniel Guimarães
Fonte: World Journal of Surgical Oncology. Unidade: FMRP
Assuntos: BIÓPSIA POR AGULHA FINA, NEOPLASIAS MAMÁRIAS, DIAGNÓSTICO POR IMAGEM, LINFONODOS, METÁSTASE LINFÁTICA, SENSIBILIDADE E ESPECIFICIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUZATTO, Isabela Panzeri Carlotti et al. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients. World Journal of Surgical Oncology, v. 19, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.1186/s12957-021-02391-3. Acesso em: 31 out. 2024.
APA
Buzatto, I. P. C., Reis, F. J. C. dos, Andrade, J. M. de, Rodrigues, T. C. G. F., Borba, J. M. C., Netto, A. H., et al. (2021). Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients. World Journal of Surgical Oncology, 19, 1-8. doi:10.1186/s12957-021-02391-3
NLM
Buzatto IPC, Reis FJC dos, Andrade JM de, Rodrigues TCGF, Borba JMC, Netto AH, Polydoro MS, Tiezzi DG. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients [Internet]. World Journal of Surgical Oncology. 2021 ; 19 1-8.[citado 2024 out. 31 ] Available from: https://doi.org/10.1186/s12957-021-02391-3
Vancouver
Buzatto IPC, Reis FJC dos, Andrade JM de, Rodrigues TCGF, Borba JMC, Netto AH, Polydoro MS, Tiezzi DG. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients [Internet]. World Journal of Surgical Oncology. 2021 ; 19 1-8.[citado 2024 out. 31 ] Available from: https://doi.org/10.1186/s12957-021-02391-3
Artigo de periodico
Effects of non-surgical periodontal therapy on the cytokine profile in gingival crevicular fluid of breast cancer patients with periodontitis undergoing chemotherapy (2021)
Villafuerte, Kelly Rocio Vargas ; Dantas, Felipe Torres; Taba Júnior, Mário ; Messora, Michel Reis ; Reis, Francisco José Candido dos ; Carrara, Helio Humberto Angotti ; Martinez, Cristhiam de Jesus Hernandez ; Gozzo, Thais de Oliveira ; Palioto, Daniela Bazan
Fonte: Supportive Care in Cancer. Unidades: FORP, EERP, FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, CITOCINAS, PERIODONTITE, FLUÍDO CREVICULAR GENGIVAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLAFUERTE, Kelly Rocio Vargas et al. Effects of non-surgical periodontal therapy on the cytokine profile in gingival crevicular fluid of breast cancer patients with periodontitis undergoing chemotherapy. Supportive Care in Cancer, v. 29, p. 7505-7513, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06194-w. Acesso em: 31 out. 2024.
APA
Villafuerte, K. R. V., Dantas, F. T., Taba Júnior, M., Messora, M. R., Reis, F. J. C. dos, Carrara, H. H. A., et al. (2021). Effects of non-surgical periodontal therapy on the cytokine profile in gingival crevicular fluid of breast cancer patients with periodontitis undergoing chemotherapy. Supportive Care in Cancer, 29, 7505-7513. doi:10.1007/s00520-021-06194-w
NLM
Villafuerte KRV, Dantas FT, Taba Júnior M, Messora MR, Reis FJC dos, Carrara HHA, Martinez C de JH, Gozzo T de O, Palioto DB. Effects of non-surgical periodontal therapy on the cytokine profile in gingival crevicular fluid of breast cancer patients with periodontitis undergoing chemotherapy [Internet]. Supportive Care in Cancer. 2021 ; 29 7505-7513.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00520-021-06194-w
Vancouver
Villafuerte KRV, Dantas FT, Taba Júnior M, Messora MR, Reis FJC dos, Carrara HHA, Martinez C de JH, Gozzo T de O, Palioto DB. Effects of non-surgical periodontal therapy on the cytokine profile in gingival crevicular fluid of breast cancer patients with periodontitis undergoing chemotherapy [Internet]. Supportive Care in Cancer. 2021 ; 29 7505-7513.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s00520-021-06194-w
Trabalho de evento-resumo periodico
Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic (2021)
Pimentel, Franklin Fernandes; Borba, Jéssica Maria Camargo; Rodrigues, Tamara Cristina Gomes Ferraz; Peruchi, Karoline P. I.; Carrara, Helio Humberto Angotti ; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos
Fonte: Cancer Research. Nome do evento: San Antonio Breast Cancer Virtual Symposium. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, TERAPÊUTICA MÉDICA, COVID-19, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Franklin Fernandes et al. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30. Acesso em: 31 out. 2024. , 2021
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2021). Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS13-30
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 out. 31 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2024 out. 31 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Fonte: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Assuntos: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, v. 185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113231. Acesso em: 31 out. 2024.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Trabalho de evento-resumo periodico
Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital (2020)
Pimentel, F. F.; Borba, Jéssica Maria Camargo; Rodrigues, T. C. G. F.; Peruchi, K. P. I.; Carrara, Helio Humberto Angotti ; Andrade, J. M.; Reis, Francisco José Candido dos
Fonte: Annals of Oncology. Nome do evento: European Society for Medical Oncology Congress - ESMO. Unidade: FMRP
Assuntos: QUIMIOTERAPIA, NEOPLASIAS MAMÁRIAS, PANDEMIAS, COVID-19, SEGURANÇA DO PACIENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, F. F. et al. Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.annonc.2020.08.1811. Acesso em: 31 out. 2024. , 2020
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M., & Reis, F. J. C. dos. (2020). Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.annonc.2020.08.1811
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM, Reis FJC dos. Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital [Internet]. Annals of Oncology. 2020 ; 31 S1020.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.annonc.2020.08.1811
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM, Reis FJC dos. Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital [Internet]. Annals of Oncology. 2020 ; 31 S1020.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.annonc.2020.08.1811
Artigo de periodico
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study (2020)
Swain, Sandra M.; Miles, David; Kim, Sung Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva M.; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefanía; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortés, Javier; Andrade, Jurandyr Moreira de
Fonte: The Lancet Oncology. Unidade: FMRP
Assuntos: ANTICORPOS MONOCLONAIS, PROTOCOLOS CLÍNICOS, QUIMIOTERAPIA COMBINADA, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, MÉTODO DUPLO-CEGO, METÁSTASE NEOPLÁSICA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWAIN, Sandra M. et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, v. 21, n. 4, p. 519-530, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(19)30863-0. Acesso em: 31 out. 2024.
APA
Swain, S. M., Miles, D., Kim, S. B., Im, Y. -H., Im, S. -A., Semiglazov, V., et al. (2020). Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, 21( 4), 519-530. doi:10.1016/S1470-2045(19)30863-0
NLM
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Vancouver
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Trabalho de evento-resumo periodico
Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery (2020)
Tiezzi, Daniel Guimarães ; Mattos, L. de; Orlandini, Leonardo Fleury ; Reis, Francisco José Candido dos ; Carrara, Helio Humberto Angotti ; Rueda, O. M.; Caldas, C.; Andrade, J. M. D.
Fonte: Annals of Oncology. Nome do evento: European Society for Medical Oncology Congress - ESMO. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, CIRURGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.annonc.2020.03.216. Acesso em: 31 out. 2024. , 2020
APA
Tiezzi, D. G., Mattos, L. de, Orlandini, L. F., Reis, F. J. C. dos, Carrara, H. H. A., Rueda, O. M., et al. (2020). Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.annonc.2020.03.216
NLM
Tiezzi DG, Mattos L de, Orlandini LF, Reis FJC dos, Carrara HHA, Rueda OM, Caldas C, Andrade JMD. Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery [Internet]. Annals of Oncology. 2020 ; 31 S54.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.annonc.2020.03.216
Vancouver
Tiezzi DG, Mattos L de, Orlandini LF, Reis FJC dos, Carrara HHA, Rueda OM, Caldas C, Andrade JMD. Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery [Internet]. Annals of Oncology. 2020 ; 31 S54.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.annonc.2020.03.216
Artigo de periodico
The genomic and immune landscape of lethal metastatic breast cancer (2019)
Matos-Arruda, Leticia de; Sammut, Stephen-John; Ross, Edith M.; Bashford-Rogers, Rachael; Greenstein, Erez; Markus, Havell; Morganella, Sandro; Teng, Yvonne; Maruvka, Yosef; Tiezzi, Daniel Guimarães
Fonte: Cell Reports. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS-ARRUDA, Leticia de et al. The genomic and immune landscape of lethal metastatic breast cancer. Cell Reports, v. 27, n. 9, p. 2690-2708, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2019.04.098. Acesso em: 31 out. 2024.
APA
Matos-Arruda, L. de, Sammut, S. -J., Ross, E. M., Bashford-Rogers, R., Greenstein, E., Markus, H., et al. (2019). The genomic and immune landscape of lethal metastatic breast cancer. Cell Reports, 27( 9), 2690-2708. doi:10.1016/j.celrep.2019.04.098
NLM
Matos-Arruda L de, Sammut S-J, Ross EM, Bashford-Rogers R, Greenstein E, Markus H, Morganella S, Teng Y, Maruvka Y, Tiezzi DG. The genomic and immune landscape of lethal metastatic breast cancer [Internet]. Cell Reports. 2019 ; 27( 9): 2690-2708.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.celrep.2019.04.098
Vancouver
Matos-Arruda L de, Sammut S-J, Ross EM, Bashford-Rogers R, Greenstein E, Markus H, Morganella S, Teng Y, Maruvka Y, Tiezzi DG. The genomic and immune landscape of lethal metastatic breast cancer [Internet]. Cell Reports. 2019 ; 27( 9): 2690-2708.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.celrep.2019.04.098
Artigo de periodico
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy (2019)
Alves, Wilson Eduardo Furlan Matos ; Bonatelli, Murilo ; Dufloth, Rozany Mucha; Kerr, Ligia Maria; Carrara, Guilherme Freire Angotti; Costa, Ricardo Filipe Alves da ; Scapulatempo Neto, Cristovam ; Tiezzi, Daniel Guimarães ; Vieira, René Aloísio da Costa ; Pinheiro, Celine Marques
Fonte: BMC Cancer. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, IMUNOQUÍMICA, QUIMIOTERAPIA ADJUVANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Wilson Eduardo Furlan Matos et al. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy. BMC Cancer, v. 19, p. [11] , 2019Tradução . . Disponível em: https://doi.org/10.1186/s12885-019-6353-2. Acesso em: 31 out. 2024.
APA
Alves, W. E. F. M., Bonatelli, M., Dufloth, R. M., Kerr, L. M., Carrara, G. F. A., Costa, R. F. A. da, et al. (2019). CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy. BMC Cancer, 19, [11] . doi:10.1186/s12885-019-6353-2
NLM
Alves WEFM, Bonatelli M, Dufloth RM, Kerr LM, Carrara GFA, Costa RFA da, Scapulatempo Neto C, Tiezzi DG, Vieira RA da C, Pinheiro CM. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy [Internet]. BMC Cancer. 2019 ; 19 [11] .[citado 2024 out. 31 ] Available from: https://doi.org/10.1186/s12885-019-6353-2
Vancouver
Alves WEFM, Bonatelli M, Dufloth RM, Kerr LM, Carrara GFA, Costa RFA da, Scapulatempo Neto C, Tiezzi DG, Vieira RA da C, Pinheiro CM. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy [Internet]. BMC Cancer. 2019 ; 19 [11] .[citado 2024 out. 31 ] Available from: https://doi.org/10.1186/s12885-019-6353-2
Artigo de periodico-carta/editorial
Current breast cancer screening scenario in Brazil. [Editorial] (2019)
Tiezzi, Daniel Guimarães ; Orlandini, Leonardo Fleury ; Carrara, Helio Humberto Angotti ; Reis, Francisco José Candido dos ; Andrade, Jurandyr Moreira de
Fonte: Revista Brasileira de Ginecologia e Obstetrícia. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, ESTATÍSTICAS DE SAÚDE, INCIDÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. Current breast cancer screening scenario in Brazil. [Editorial]. Revista Brasileira de Ginecologia e Obstetrícia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1055/s-0039-3399550. Acesso em: 31 out. 2024. , 2019
APA
Tiezzi, D. G., Orlandini, L. F., Carrara, H. H. A., Reis, F. J. C. dos, & Andrade, J. M. de. (2019). Current breast cancer screening scenario in Brazil. [Editorial]. Revista Brasileira de Ginecologia e Obstetrícia. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1055/s-0039-3399550
NLM
Tiezzi DG, Orlandini LF, Carrara HHA, Reis FJC dos, Andrade JM de. Current breast cancer screening scenario in Brazil. [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2019 ; 41( 11): 633-635.[citado 2024 out. 31 ] Available from: https://doi.org/10.1055/s-0039-3399550
Vancouver
Tiezzi DG, Orlandini LF, Carrara HHA, Reis FJC dos, Andrade JM de. Current breast cancer screening scenario in Brazil. [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2019 ; 41( 11): 633-635.[citado 2024 out. 31 ] Available from: https://doi.org/10.1055/s-0039-3399550

Unidades USP

ReP

Filtros

Tipo de material

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos